Phyllis Arthur's Testimony to Senate HELP Committee on Lessons Learned from Covid-19
July 27, 2021
COVID-19 will not be our last public health emergency. We face numerous bio-threats from natural and bioterror threats. Strong support for medical countermeasures R&D is critical to protecting our national security.
Today I will share BIO’s thoughts on how to strengthen our national preparedness through coordinated leadership, expanded partnership with industry and better public health infrastructure.
Chairman Cassidy, Ranking Member Sanders, and distinguished Members of the Committee:Thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), which represents more than 1,000…
Phyllis Arthur, EVP, Health Policy and Programs, “Vaccines are one of the most important and effective innovations for the defense of public health. They have saved millions of lives and drastically reduced or eliminated deadly and debilitating…
Re: Docket No. CDC-2025-0454; Advisory Committee on Immunization Practices (ACIP)The Biotechnology Innovation Organization (BIO) is appreciative of the opportunity to provide comments to the Advisory Committee on Immunization Practices (ACIP) in…
COVID-19 will not be our last public health emergency. We face numerous bio-threats from natural and bioterror threats. Strong support for medical countermeasures R&D is critical to protecting our national security.
Today I will share BIO’s thoughts on how to strengthen our national preparedness through coordinated leadership, expanded partnership with industry and better public health infrastructure.